Innovative Device Offers Long-Term Relief

Dental Products Report, Dental Products Report March 2021, Volume 55, Issue 3

Proprietary Vivos System treatment offers OSA patients the prospect of effective, limited-duration treatment with lasting results.

Information provided by Vivos Therapeutics.


The Vivos System consists of proprietary, FDA-registered, and cleared custom appliances, specific materials, and advanced protocols. Central are the company’s patented DNA (pictured) and mRNA appliances.


Vivos Therapeutics
866-908-4867 |


Any practice seeking to resolve patients’ obstructed sleep apnea.

Reportedly between 33% and 50% of the patients whom dentists see are suffering from OSA. With the Vivos System, dentists can now make a lasting impact on the overall health and wellbeing of their patients.


The Vivos System is designed to bring patients lasting relief from their OSA symptoms without a lifetime of intervention. Other treatment options must reportedly be worn or used every night to be effective. Mandibular advancement appliances are palliative and must be worn for life to be effective. Treatment with the Vivos System is said to take just 12 to 24 months, after which no further intervention is required.


The Vivos System is designed to remodel and enhance the hard and soft tissues that define and shape the airway. Studies have shown that, as treatment progresses, patients’ airways remodel and expand, becoming less prone to apneas. Mandibular advancement oral appliances are not designed to function in that way. The Vivos System offers patients treatment designed to adjust the airway itself so that it functions the way it is meant to during sleep.